Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionEngineers Gate Manager LP
Latest Disclosed Ownership63,873 shares
Latest Disclosed Value $ 894,861
Engineers Gate Manager LP reports 45.44% decrease in ownership of AVNS / Avanos Medical, Inc.

On May 15, 2026 - Engineers Gate Manager LP filed a 13F-HR form disclosing ownership of 63,873 shares of Avanos Medical, Inc. (US:AVNS) valued at $894,861 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 117,063 shares of Avanos Medical, Inc.. This represents a change in shares of -45.44% during the quarter. The current value of the position is $1,595,548 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVANOS MED COM 05350V106 63,873 -53,190 -45.44 895 -31.96 0.0112
2026-02-17 2025-12-31 13F AVANOS MED COM 05350V106 117,063 57,990 98.17 1,315 92.67 0.0156
2025-11-14 2025-09-30 13F AVANOS MED COM 05350V106 59,073 -27,524 -31.78 683 -35.60 0.0078
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 86,597 55,687 180.16 1,060 139.59 0.0132
2025-05-15 2025-03-31 13F AVANOS MED COM 05350V106 30,910 -15,130 -32.86 443 -39.62 0.0075
2025-02-14 2024-12-31 13F AVANOS MED COM 05350V106 46,040 -907 -1.93 733 -35.11 0.0128
2024-11-14 2024-09-30 13F AVANOS MED COM 05350V106 46,947 -3,188 -6.36 1,128 13.03 0.0220
2024-08-14 2024-06-30 13F AVANOS MED COM 05350V106 50,135 -20,997 -29.52 999 -29.52 0.0225
2024-05-15 2024-03-31 13F AVANOS MED COM 05350V106 71,132 6,488 10.04 1,416 -2.28 0.0373
2024-02-14 2023-12-31 13F AVANOS MED COM 05350V106 64,644 25,844 66.61 1,450 84.82 0.0414
2023-11-14 2023-09-30 13F AVANOS MED COM 05350V106 38,800 29,530 318.55 785 232.20 0.0290
2023-08-14 2023-06-30 13F AVANOS MED COM 05350V106 9,270 -643 -6.49 237 -19.73 0.0090
2023-05-15 2023-03-31 13F AVANOS MED COM 05350V106 9,913 -5,058 -33.79 295 -27.41 0.0123
2023-02-14 2022-12-31 13F AVANOS MED COM 05350V106 14,971 -24,989 -62.54 405 -53.45 0.0243
2022-11-14 2022-09-30 13F AVANOS MED COM 05350V106 39,960 39,960 870 0.0541
2022-08-15 2022-06-30 13F AVANOS MED COM 05350V106 0 -39,153 -100.00 0 -100.00
2022-05-16 2022-03-31 13F AVANOS MED COM 05350V106 39,153 3,681 10.38 1,312 6.67 0.0513
2022-02-14 2021-12-31 13F AVANOS MED COM 05350V106 35,472 -25,738 -42.05 1,230 -35.60 0.0553
2021-11-15 2021-09-30 13F AVANOS MED COM 05350V106 61,210 61,210 1,910 0.1088
2021-05-17 2021-03-31 13F AVANOS MED COM 05350V106 0 -5,800 -100.00 0 -100.00
2021-02-16 2020-12-31 13F AVANOS MED COM 05350V106 5,800 -4,139 -41.64 266 -19.39 0.0115
2020-11-16 2020-09-30 13F AVANOS MED COM 05350V106 9,939 9,939 330 0.0155
2020-08-17 2020-06-30 13F AVANOS MED COM 05350V106 0 -28,360 -100.00 0 -100.00
2020-05-15 2020-03-31 13F AVANOS MED COM 05350V106 28,360 -39,077 -57.95 764 -66.39 0.0550
2020-02-14 2019-12-31 13F AVANOS MED COM 05350V106 67,437 61,759 1,087.69 2,273 967.14 0.1000
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 5,678 5,678 213 0.0108
2019-08-14 2019-06-30 13F AVANOS MED COM 05350V106 0 -63,735 -100.00 0 -100.00
2019-05-15 2019-03-31 13F AVANOS MED COM 05350V106 63,735 30,703 92.95 2,720 83.78 0.1647
2019-02-14 2018-12-31 13F AVANOS MED COM 05350V106 33,032 33,032 1,480 0.1184
2015-11-16 2015-09-30 13F HALYARD HEALTH COM 40650V100 0 -52,191 -100.00 0 -100.00
2015-08-14 2015-06-30 13F HALYARD HEALTH COM 40650V100 52,191 34,713 198.61 2,114 145.81 0.2069
2015-05-15 2015-03-31 13F HALYARD HEALTH COM 40650V100 17,478 17,478 860 0.1144
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.